pembrolizumab for non-clear cell rcc
Published 2 years ago • 13 plays • Length 3:04Download video MP4
Download video MP3
Similar videos
-
0:59
combining lenvatinib & pembrolizumab for non-clear cell rcc: keynote-b61 study rationale
-
1:28
keynote-b61: first-line lenvatinib pembrolizumab in non-clear cell rcc
-
1:14
dr. jonasch on single-agent pembrolizumab in non-clear cell rcc
-
5:29
drs. lee, mckay on keynote-b61 for non-clear cell rcc
-
5:05
cabozantinib plus atezolizumab for non-clear cell renal cell carcinoma
-
6:41
pembrolizumab as adjuvant therapy for patients with renal cell carcinoma
-
1:10
dr. mcdermott on the promise of pembrolizumab in non-clear cell rcc
-
2:18
pembrolizumab monotherapy and pembro-axitinib for rcc
-
10:06
lenvatinib and pembrolizumab compared to sunitinib for advanced renal cell carcinoma
-
6:25
contextualizing new data on checkpoint inhibitors for non-clear cell rcc
-
1:49
using combination therapy as treatment of non-clear cell rcc
-
5:00
keynote-b61: putting a focus on non-clear cell rcc treatment
-
1:20
promising results of cabozantinib plus nivolumab in non-clear cell rcc
-
1:51
dr. srinivasan on targeted therapies for non-clear cell rcc
-
1:00
adjuvant pembrolizumab in kidney cancer from keynote 564
-
5:04
keynote-427 cohort b: first-line pembrolizumab monotherapy for advanced non-clear cell renal cel...
-
5:14
lenvatinib plus pembrolizumab after progression on immune checkpoint inhibitors for metastatic rcc
-
4:57
review of the data of frontline treatment for non-clear cell kidney cancer
-
4:17
longer term outcomes with pembrolizumab plus axitinib for advanced rcc